Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis
Gary S. Firestein
Gary S. Firestein
Published August 16, 2004
Citation Information: J Clin Invest. 2004;114(4):471-474. https://doi.org/10.1172/JCI22651.
View: Text | PDF | Erratum
Commentary

The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis

  • Text
  • PDF
Abstract

The etiology of autoimmunity in humans remains poorly defined, and animal models provide a unique opportunity to study potential autoimmune mechanisms. A novel model of autoimmune inflammatory arthritis results from a point mutation in the ζ-associated–protein of 70 kDa (ZAP-70), which causes abnormal thymic T cell selection and survival of autoreactive clones. Although the resulting clinical and pathologic abnormalities are clearly T cell–dependent, macrophage and fibroblast cytokines such as IL-1 and TNF-α are required for full expression of the disease. The studies of Hata et al. raise the intriguing possibility that traditional proinflammatory cytokine networks represent common effector mechanisms in inflammatory joint diseases such as rheumatoid arthritis. Hence, effective therapeutic interventions can target either unique etiologic pathways related to adaptive immune responses or shared terminal mechanisms.

Authors

Gary S. Firestein

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Sequence of events implicated in naive T cell activation. The T cell rec...
Sequence of events implicated in naive T cell activation. The T cell receptor (TCR) complex, including the CD3 complex and ζ-chains, are expressed by resting naive T cells adjacent to lipid rafts that contain LAT, CD4, and kinases like Lck (A). Ligation of the TCR by antigen and MHC class II protein recruits CD4 and costimulatory molecules like CD28, which engage MHC and CD80/86, respectively. Activated Lck and other kinases then phosphorylate (P) the ζ-chain, which, in turn, recruits ZAP-70 (B). ZAP-70 is also phosphorylated by Lck and other kinases in this process and can, in turn, phosphorylate numerous downstream substrates, including MAPKs and many other signaling pathways (C). PLCγ, phospholipase Cγ.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts